Manufacturing
Nurixâs B-cell cancer drug on partial hold by FDA over manufacturing issues
Nurix Therapeutics has temporarily halted a phase 1 trial for its B-cell malignancy drug, NX-2127, as it undertakes a manufacturing ...
RLS to offer CDMO services for radiopharma at 8 US locations
The biopharmaceutical landscape is witnessing a seismic shift towards radiopharmaceuticals, with major players like Eli Lilly making substantial investments, exemplified ...
Novo Nordisk Foundation Cellerator to boost cell therapy development and production in Denmark
The Novo Nordisk Foundation is embarking on a mission to establish a pivotal “hub” within the cell therapy ecosystem by ...
Moderna to cut down COVID booster production amid low demand: Reuters reports
While the FDA and the Centers for Disease Control and Prevention (CDC) have given their green light to updated COVID ...
Moderna to research and manufacture mRNA meds in China under $1B agreement
Despite ongoing political tensions between the United States and China, foreign investments in the pharmaceutical sector are progressing in China. ...